Market Highlights

• Integra LifeSciences plans to resume the manufacturing of its two products, PriMatrix and SurgiMend, at its new facility in Braintree.
• Vertex Pharmaceuticals has announced the renewal of its 1.1 million square foot (msf) headquarters lease at 11 Fan Pier Boulevard and 50 Northern Avenue.
• Cardurion Pharmaceuticals has raised $260.0 million to advance late-stage clinical trials for its two leading drug candidates targeting heart failure with preserved ejection fraction and heart failure with reduced ejection fraction.

Read the full report